仿生眼市场规模、份额、成长分析、按类型、按技术、按人工替代物系统、按最终用户、按地区 - 行业预测，2025-2032 年

2023年仿生眼市场规模将为3.015亿美元，预测期内（2025-2032年）复合年增长率为12.88%，从2024年的3.4033亿美元增至2032年的8.971亿美元。

在视网膜疾病盛行率上升、人口老化和技术进步的推动下，全球仿生眼市场正在强劲成长。视网膜疾病的日益普及增加了对创新视力恢復解决方案的需求，这些解决方案可以解决日益受到视力障碍影响的人。仿生眼技术的最新创新催生了复杂的系统，该系统整合了植入式设备和外部摄像头，以改善视力和整体性能。然而，挑战仍然存在，包括仿生植入和外科手术相关的高成本，这限制了可近性，特别是在发展中地区。此外，这些设备的长期安全性和有效性仍在调查中，监管核准和不同的报销政策为市场扩张带来了额外的障碍。

目录

介绍

• 研究目的
• 调查范围
• 定义

调查方法

• 资讯采购
• 二手资料和主要资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 按细分市场的机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 抑制因素和挑战
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024年）
• PESTEL分析
• 总体经济指标
• 价值链分析
• 价格分析

仿生眼市场规模：依类型

• 市场概况
• 外眼
• 移植眼

仿生眼市场规模：依人工替代物系统分类

• 市场概况
• Argus II
• Alpha IMS
• Alpha AMS
• IRIS II
• 其他的

仿生眼市场规模：依技术划分

• 市场概况
• 电子的
• 机器

仿生眼市场规模：依最终用户分类

• 市场概况
• 医院
• 眼科诊所
• 其他的

仿生眼市场规模

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东/非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东/非洲

竞争资讯

• 前5名企业对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2024年）
• 主要企业简介
  • 公司简介
  • 产品系列分析
  • 按细分市场分類的份额分析
  • 收益与前一年同期比较（2022-2024）

主要企业简介

• Second Sight Medical Products, Inc.（USA）
• Pixium Vision（France）
• Monash Vision Group（Australia）
• Nano Retina Ltd.（Israel）
• Optobionics Corporation（Japan）
• Nidek Co., Ltd.（Japan）
• Bionic Vision Technologies（Australia）
• iBionics（USA）
• Vivani Medical Inc.（USA）
• MetaModal LLC（USA）
• Biomedical Technologies SL（Spain）

结论和建议

Bionic Eye Market size was valued at USD 301.5 Million in 2023 and is poised to grow from USD 340.33 Million in 2024 to USD 897.1 Million by 2032, growing at a CAGR of 12.88% during the forecast period (2025-2032).

The global bionic eye market is witnessing robust growth, fueled by the rising prevalence of retinal diseases, an aging population, and technological advancements. Increased incidence of retinal disorders amplifies the demand for innovative vision restoration solutions, catering to a demographic increasingly affected by vision impairments. Recent innovations in bionic eye technology have led to the creation of sophisticated systems that integrate implantable devices with external cameras, enhancing visual acuity and overall performance. However, challenges persist, including high costs associated with bionic implants and surgical procedures, which limit accessibility, especially in developing regions. Additionally, the long-term safety and efficacy of these devices remain under investigation, while obtaining regulatory approvals and navigating diverse reimbursement policies present further hurdles to market expansion.

Top-down and bottom-up approaches were used to estimate and validate the size of the Bionic Eye market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Bionic Eye Market Segmental Analysis

Global Bionic Eye Market is segmented by type, technology, end users, prosthesis system and region. Based on type, the market is segmented into external eye and implanted eye. Based on technology, the market is segmented into electronic and mechanical. Based on prosthesis system, the market is segmented into Argus II, Alpha IMS, Alpha AMS, IRIS II, and Others. Based on end users, the market is segmented into hospitals, ophthalmic clinics and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Bionic Eye Market

The bionic eye market is significantly driven by the growing prevalence of retinal diseases, including conditions like retinitis pigmentosa and age-related macular degeneration. As more individuals experience severe vision impairments or blindness attributable to these retinal disorders, there is an escalating demand for bionic eye technology as a viable solution for vision restoration. This increasing patient population creates a compelling need for innovative interventions, thus propelling advancements and investments in bionic eye technologies. With the potential to transform lives through improved vision capabilities, the bionic eye sector is positioned for substantial growth in response to this rising healthcare challenge.

Restraints in the Bionic Eye Market

Restraints in the Bionic Eye market primarily stem from the high expenses associated with bionic eye implants and the surgical procedures required for their installation. This elevated cost acts as a substantial hindrance to market expansion, as it restricts access to these innovative devices, particularly in areas with underdeveloped healthcare systems or limited reimbursement options. The financial burdens related to affordability and reimbursement pose significant challenges that discourage the widespread adoption of bionic eye technology. Consequently, these factors contribute to a slower integration of bionic eye solutions across various markets, limiting their potential benefits for those in need.

Market Trends of the Bionic Eye Market

The bionic eye market is witnessing a significant trend towards miniaturization and implantable designs, enhancing both functionality and patient experience. As devices become more compact, they facilitate easier surgical implantation, resulting in heightened comfort for users. Innovations in wireless power and data transmission are transforming the landscape of bionic eye technology, allowing for seamless integration into the human body. This shift not only caters to patient demand for discreet solutions but also propels advancements in vision restoration capabilities, indicating a robust future for the bionic eye market as it aligns with the broader movement towards personalized and minimally invasive medical devices.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Bionic Eye Market Size by Type & CAGR (2025-2032)

• Market Overview
• External Eye
• Implanted Eye

Global Bionic Eye Market Size by Prosthesis System & CAGR (2025-2032)

• Market Overview
• Argus II
• Alpha IMS
• Alpha AMS
• IRIS II
• Others

Global Bionic Eye Market Size by Technology & CAGR (2025-2032)

• Market Overview
• Electronic
• Mechanical

Global Bionic Eye Market Size by End Users & CAGR (2025-2032)

• Market Overview
• Hospitals
• Ophthalmic Clinics
• Others

Global Bionic Eye Market Size & CAGR (2025-2032)

• North America (Type, Prosthesis System, Technology, End Users)
  • US
  • Canada
• Europe (Type, Prosthesis System, Technology, End Users)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Prosthesis System, Technology, End Users)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Prosthesis System, Technology, End Users)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Prosthesis System, Technology, End Users)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Second Sight Medical Products, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pixium Vision (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Monash Vision Group (Australia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nano Retina Ltd. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Optobionics Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nidek Co., Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bionic Vision Technologies (Australia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• iBionics (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vivani Medical Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MetaModal LLC (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biomedical Technologies S.L. (Spain)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations